Avania is committed to taking part in the fight against COVID-19. We appreciate that the state of clinical research remains in question and many of our research sponsors and colleagues are facing a number of challenges, including clinical sites curbing subject enrollment, limiting ability to interact with clinical research staff, and concerning subject follow-up visits.
We have mobilized our global capabilities and resources to help our clients reduce the impact of this virus on their clinical development programs. Our clinical trial experts have been working closely with clients to develop plans that facilitate new options to ensure clinical trial success. These include options for ePRO tools that facilitate telemedicine to complete follow-up assessments, use of remote clinical site interactions, and development of adjusted protocols and statistical plans.
We welcome meeting with you virtually to share more about our efforts and discuss your specific concerns and plans as you address the COVID-19 pandemic to ensure successful trial execution.
The Avania Team